The PGE project - Development of compounds that inhibit PGE2 synthesis to treat chronic inflammation

The PGE project has resulted in a spin-off company, NovaSAID AB. For additional information please see www.novasaid.com. Project management and further development is done by Actar AB on a contract basis.